Background The current treatment results of laryngeal squamous cell carcinoma still remain
modest. Various prognostic factors have been investigated and need to be included in the …

For the treatment of early and locally advanced glottic laryngeal cancer, multiple strategies
are available. These are pursued and supported by different levels of evidence, but also by …

Purpose Multiple smaller studies have demonstrated an association between overall
survival and lymph node (LN) count from neck dissection in patients with head and neck …

BACKGROUND The treatment of head and neck cancers is complex and associated with
significant morbidity, requiring multidisciplinary care and physician expertise. Thus, facility …

Importance Agreement between patient-and practitioner-reported toxic effects during
chemoradiotherapy for head and neck cancer is unknown. Objective To compare patient …

Background Lenvatinib is a multi-kinase inhibitor approved for patients with radioactive
iodine (RAI)–resistant differentiated thyroid cancer (DTC). Before the drug approval from the …

Objective To report the incidence of positive surgical margins in early oral cavity cancer and
identify patient, tumor, and system factors associated with their occurrence. Study Design …

Background Treatment durations and factors associated with delays for oral cavity
squamous cell carcinoma (SCC) have previously been described but are not fully …

Objective Undergoing surgery and adjuvant radiotherapy (aRT) at the same facility has been
associated with higher overall survival (OS) in head and neck squamous cell carcinoma. Our …

Importance Most patients with oral cavity squamous cell cancer (OCSCC) are initially seen
at an early stage (I and II). Although patient and tumor prognostic features have been …